A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors

Leukemia

Volumn 11, Issue 10, 1997, Pages 1793-1798

  Voena, C ^a,c   Ladetto, M ^a   Astolfi, M ^a   Provan, D ^b   Gribben, J G ^b   Boccadoro, M ^a   Pileri, A ^a   Corradini, P ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Cattedra di Ematologia   (Italy)

Author keywords

B cell malignancies; IgH nested PCR; Minimal residual disease

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; B CELL LEUKEMIA; CHROMOSOME TRANSLOCATION; DNA TEMPLATE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

EID: 0030698409     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400801     Document Type: Article

References (13)

1. Vose JM, Armitage JO. Role of autologous bone marrow transplantation in non-Hodgkin lymphoma. Hematol/Oncol Clin N Am 1993; 7: 577-590.
2. Gianni AM, Tarella C, Bregni M, Siena S, Lombardi F, Gandola L, Caracciolo D, Stern A, Bonadonna G, Boccadoro M, Pileri A. High-dose sequential chemoradiotherapy, a widely applicable regimen confers survival benefit to patients with high-risk multiple myeloma. J Clin Oncol 1994; 12: 503-509.
3. Preti A, Kantarjian HG. Management of adult acute lymphocytic leukemia: present issues and key challenges. J Clin Oncol 1994; 12: 1312-1322.
4. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995; 85: 1416-1434.
5. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 2449-2457.
6. Brisco MJ,. Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogod I, Waters K, Tauro G, Ekert H, Morley AA. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343: 196-200.
7. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang G-S, Zhang F-Q, Chai J-R, Wang ZY, Waxmann S, Chen Z, Chen S-J. Acute promyelocytic leukemia: clinical relevance of two major PML/RAR-α isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264-1269.
8. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati A, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437-1438.
9. Negrin RS, Blume KG. The use of polymerase chain reaction for the detection of minimal residual malignant disease. Blood 1991; 78: 255-258.
10. Cross NCP, Feng L, Chas A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1938.
11. Yamada M, Wasserman R, Lange B, Richard BA, Womer RB, Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemia cells during the first 18 months of treatment. New Engl J Mod 1990; 323: 448-455.
12. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-1463.
13. Bartram CR. Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy. Clin Chim Acta 1993; 217: 75-78.